You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
A monoclonal antibody treatment from Eli Lilly may slow the progression of Alzheimer's disease, the New York Times reports.
The Washington Post reports there is no evidence that the rise in COVID-19 cases in the US is due to a particular strain, but notes scientists' ability to detect variants is limited.
In PNAS this week: droplet-based mRNA sequencing strategy, secretome mouse model, and more.
BBC News says the UK is rolling out rapid COVID-19 testing for asymptomatic people despite concerns over its accuracy.
The Associated Press reports a preliminary study suggests the Pfizer-BioNTech vaccine is effective against the new SARS-CoV-2 variant.
Bluebird Bio is splitting into two companies, the Wall Street Journal reports.
In PLOS this week: potential neuropsychiatric drug targets identified, analysis of foodborne pathogen genome, and more.
A lack of a national SARS-CoV-2 genome sequencing strategy is hindering the ability of the US to track and uncover emerging SARS-CoV-2 strains, according to the New York Times.
ScienceInsider reports on the political quagmire affecting the Science Council of Japan.
The researcher accused of attempting to smuggle research materials out of the US has been sentenced to time served, according to the Associated Press.
In Science this week: mapping the embryonic mouse heart, and more.
In a new study, researchers used base editing to extend the lives of mice with a premature aging syndrome.
Bryan Sykes, an Oxford University professor who studied genetic ancestry, has died at 73, the New York Times reports.
The Financial Times reports gene-edited crops and livestock may soon be allowed in the UK.
In Nature this week: reference genomes for the platypus and echidna, single-cell RNA sequencing analysis of gastric adenocarcinoma, and more.
South African researchers are investigating whether COVID-19 vaccines are effective against a SARS-CoV-2 strain recently identified there, the Associated Press reports.
The Wall Street Journal reports the European Medicines Agency has approved Moderna's SARS-CoV-2 vaccine.
The Guardian reports that visas for some members of the World Health Organization team investigating the origins of SAR-CoV-2 have not yet been approved by China.
In Genome Biology this week: loci linked to longitudinal pediatric bone accrual, role of complement cascade gene in pancreatic cancer metastases, and more.
The Wall Street Journal reports that the company launched by Amazon, Berkshire Hathaway, and JPMorgan Chase to transform healthcare is closing.
A Centers for Disease Control and Prevention official tells CNN the agency plans to boost the number of SARS-CoV-2 samples that are sequenced in the US.
Wired speaks with National Human Genomics Research Institute's Eric Green about the Human Genome Project.
In PNAS this week: selection affecting inborn errors of immunity, structure of an ADP ribose-hydrolyzing protein macrodomain in a bat coronavirus, and more.
China has approved a SARS-CoV-2 vaccine developed by the state-owned Sinopharm, according to NPR.
Science notes that the open-access requirements of Plan S go into effect this month.
The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.
According to the Associated Press, a Swiss program aims to shepherd long-term science projects and diplomacy.
CNN reports that two new studies suggest the B.1.1.7 SARS-CoV-2 variant may be more transmissible, but may not lead to more severe disease.
In PNAS this week: analysis of pathway affecting acute kidney injury, parental-specific allelic expression in horse placenta, and more.